about
Allergens, sources, particles, and molecules: Why do we make IgE responses?Rhinovirus infection results in stronger and more persistent genomic dysregulation: Evidence for altered innate immune response in asthmatics at baseline, early in infection, and during convalescencePathogenic CD4+ T cells in patients with asthma.Circulating Memory CD4+ T Cells Target Conserved Epitopes of Rhinovirus Capsid Proteins and Respond Rapidly to Experimental Infection in Humans.Half-life of IgE in serum and skin: Consequences for anti-IgE therapy in patients with allergic disease.IgE in the diagnosis and treatment of allergic disease.The discovery of IgE 50 years later.Antigenic Determinants of the Bilobal Cockroach Allergen Bla g 2.The immune response to intrinsic and extrinsic allergens: determinants of allergic disease.Mechanisms of tolerance to inhalant allergens: the relevance of a modified Th2 response to allergens from domestic animals.The role of regulatory T cells in atopic dermatitis.Skin barrier defects in atopic dermatitisA molecular perspective on TH2-promoting cytokine receptors in patients with allergic disease.Mast Cell-Activated Bone Marrow Mesenchymal Stromal Cells Regulate Proliferation and Lineage Commitment of CD34(+) Progenitor Cells.Galactose-α-1,3-galactose-specific IgE is associated with anaphylaxis but not asthma.Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactoseFlow cytometry imaging identifies rare T(H)2 cells expressing thymic stromal lymphopoietin receptor in a "proallergic" milieu.A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen.T cell epitope-specific defects in the immune response to cat allergen in patients with atopic dermatitis.Targeting allergen to FcgammaRI reveals a novel T(H)2 regulatory pathway linked to thymic stromal lymphopoietin receptor.Cat and dust mite sensitivity and tolerance in relation to wheezing among children raised with high exposure to both allergens.Allergy and dermatophytes.Specific IgE and IgG antibody-binding patterns to recombinant cockroach allergens.High-dose allergen exposure leads to tolerance.A new paradigm for immunoglobulin E in allergic diseases.Quantitative measurement of IgE antibodies to purified allergens using streptavidin linked to a high-capacity solid phase.Airborne endotoxin in homes with domestic animals: implications for cat-specific tolerance.Targeting allergen to Fc gammaRI: a strategy to treat allergic disease?Environmental factors influencing allergy and asthma.Selective roles and dysregulation of interleukin-10 in allergic disease.T-cell responses to allergens.The relevance of microbial allergens to the IgE antibody repertoire in atopic and nonatopic eczema.Prevalence and titer of IgE antibodies to mouse allergens.Targeting Fel d 1 to FcgammaRI induces a novel variation of the T(H)2 response in subjects with cat allergy.Analysis of CD25hiCD4+ "regulatory" T-cell subtypes in atopic dermatitis reveals a novel T(H)2-like population.Markers for host-induced gene expression in Trichophyton dermatophytosisEpitope-specific T-cell responses and allergic phenotypes: implications for T-cell peptide therapy.Allergens and their role in the allergic immune response.Changes in cat specific IgE and IgG antibodies with decreased cat exposure.Bla g 6: a troponin C allergen from Blattella germanica with IgE binding calcium dependence.
P50
Q26782482-02424BC4-A192-494E-BD16-2349FF73B4A2Q30252319-CD95B8B1-AB17-4DE3-9E44-B71F5C3B3D6AQ30252507-0E6F24D7-802E-448D-A706-12DB8905B192Q30276004-5ACD4B60-0AAC-449F-AD8E-279405984FB1Q30276181-C2C52257-72A7-4FE7-9C1C-75494F0664D9Q30276662-61DCC2DE-CEC4-45E4-8907-DD053426647AQ30277204-37E2E51F-0D1A-4FF7-A681-8D9A4C2C9240Q30277948-1613A683-7CF5-4468-B718-B4AA6824207EQ30310321-C70D4568-EB4B-46D1-9C56-352589B923D3Q30312251-751557EE-D1DB-4EFE-925A-222CAE5686BEQ30371308-638A7850-2B62-456A-9C82-0ACB694FBD69Q30405464-263D0BCF-E668-4589-A162-E29987978D59Q30406072-D4C53D85-E978-449D-B48D-689CF7AA372DQ30415602-5BC0EF0A-B013-4F71-9E2D-C20DA04F0483Q30424672-2A046E87-71E5-47BA-A540-6FCBF09014CEQ30427410-D2076F80-2C5E-4A96-B417-056BEA07D179Q30429961-13D89082-347C-4141-89E5-A90442A647C7Q30433007-DBCC36CD-D08F-4E98-A41E-72D57607D635Q30433359-73BA5D3F-8F7C-4B37-AA0F-F4BCA26CC15CQ30433654-204E3CD0-739C-46E8-9030-FE96ABC88A69Q30435585-52EC2460-C875-4015-9283-1D5F5CBCF527Q30435661-26BCC1F3-23CF-4405-A508-885256B7C5B8Q30436443-B80C2A79-B697-490C-9726-9F01D44A393CQ30436564-33344BE5-A020-4E58-9D56-AC55E156ACD0Q30436615-33D64930-0379-4905-85A2-A14A64352CADQ30436752-E198C75F-F110-4E50-A1DF-8F7AE9088B86Q30437671-61BE62C5-3DE8-434E-BBDB-9926A2571D89Q30437725-5F61AA7C-3191-4061-BC1C-246DA57B45A3Q30438974-B3DB8AD7-6FEE-457B-92CD-B5BCFD7711B0Q30439533-8404E505-6857-4B0F-9D8A-19BC40CAC2F6Q30442898-15DD7EF9-8D19-4C56-B71E-A5CEC93C21B5Q30443650-A01D7127-D589-401E-996D-7E61DC4B0B2EQ30444411-1A96386D-6B72-43B6-B0E1-57976D48E46FQ30445228-2E03017C-846D-4AD2-BF6C-52702AAEAF14Q30445344-9D23D42A-80CA-4034-8B27-798CD4ABC27BQ30447804-22EFC7AA-17B0-42E6-AC52-069C0A45BC5FQ30450873-F5E66209-FF70-48BD-891E-B7E0AD53CD24Q30453700-15EB0A61-1CBA-4137-A615-A4A4286C5B3CQ30457847-D050D386-3EE3-4774-BCB0-7F3FC6CE3E99Q33245619-22ED3FF4-8736-4620-9C24-019F93D8E355
P50
name
Judith A Woodfolk
@en
type
label
Judith A Woodfolk
@en
prefLabel
Judith A Woodfolk
@en